Related Experiment Video
Updated: Aug 11, 2026

Methylated DNA Immunoprecipitation
Published on: January 2, 2009
Cancer epigenetics
1Department of Surgery and Biochemistry and Molecular Biology, University of Southern California, 90086-9176, USA.
Abstract:
The field of cancer epigenetics is evolving rapidly on several fronts. Advances in our understanding of chromatin structure, histone modification, transcriptional activity and DNA methylation have resulted in an increasingly integrated view of epigenetics. In response to these insights, epigenetic therapy is expanding to include combinations of histone deacetylase inhibitors and DNA methyltransferase inhibitors. Zebularine, an orally administerable DNA methyltransferase inhibitor, has been a very promising recent addition to our arsenal of potentially useful drugs for epigenetic therapy. Aberrant DNA methylation patterns provide three powerful diagnostic applications as classification markers, sensitive detection markers, and risk assessment markers. Classification studies continue to increase in marker complexity, now incorporating microarrays, high-throughput bisulfite genomic sequencing and mass spectrometry, as the field moves to human epigenome projects. Sensitive detection technology has expanded from primarily blood-based cancer detection to include applications on a wide diversity of sample sources and is now also making inroads as a molecular risk assessment tool.
Insights
Cancer epigenetics is advancing with new therapies and diagnostic tools. DNA methylation patterns are key for classifying, detecting, and assessing cancer risk, improving patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer epigenetics is rapidly evolving, integrating knowledge of chromatin structure, histone modification, transcriptional activity, and DNA methylation.
- Epigenetic therapy is expanding to include combination treatments, such as histone deacetylase inhibitors and DNA methyltransferase inhibitors.
Purpose of the Study:
- To highlight recent advances in cancer epigenetics, focusing on therapeutic strategies and diagnostic applications.
- To discuss the role of DNA methylation in cancer classification, detection, and risk assessment.
Main Methods:
- Review of current research in epigenetic therapy and diagnostic marker development.
- Incorporation of technologies like microarrays, high-throughput bisulfite genomic sequencing, and mass spectrometry for epigenome analysis.
Main Results:
- Zebularine, an oral DNA methyltransferase inhibitor, shows promise for epigenetic therapy.
- Aberrant DNA methylation patterns are effective as classification, sensitive detection, and risk assessment markers.
- Sensitive detection technologies are expanding beyond blood-based tests to diverse sample sources and risk assessment.
Conclusions:
- Epigenetic therapy is becoming more sophisticated with combination treatments.
- DNA methylation analysis offers powerful diagnostic and prognostic applications in oncology.
- Technological advancements are enhancing the scope and utility of epigenetic markers in cancer management.
Related Concept Videos
Epigenetic Regulation
Cancer
Epigenetic Regulation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Epigenetic Regulation
X-chromosome...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

